Clinical trial
Evaluation of the Impact of Reduced Immunosuppression on Graft-versus-host Disease and Rejection Rates in Orthotopic Liver Transplant Recipients
NCT05238155 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Impact of Reduced Immunosuppression on Graft-versus-host Disease and Rejection Rates in Orthotopic Liver Transplant Recipients
- Lead sponsor
- Methodist Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 19, 2021
- Completion date
- July 29, 2025
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.